/PILA.ST
PILA.ST Stock - Pila Pharma AB (publ)
Healthcare|BiotechnologySTO
$2.20+2.80%
+$0.06 (+2.80%) • Dec 23
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.18
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.42
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PILA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.18 – $2.22
TARGET (TP)$2.53
STOP LOSS$2.02
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.42
52W High$5.56
52W Low$1.98
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $775,000 | $1.46M | $1.88M | $719,230 | N/A |
| Gross Profit | $-8,124,139 | $1.46M | $1.88M | $680,939 | $-492,392 |
| Gross Margin | -1048.3% | 100.0% | 100.0% | 94.7% | N/A |
| Operating Income | $-8,109,000 | $-6,393,249 | $-8,890,095 | $-9,260,595 | $-3,379,382 |
| Net Income | $-11,241,000 | $-9,930,009 | $-26,776,732 | $-17,207,264 | $-10,584,135 |
| Net Margin | -1450.5% | -678.7% | -1423.7% | -2392.5% | N/A |
| EPS | $-0.44 | $-0.47 | $-1.55 | $-1.32 | $-0.67 |
Company Overview
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PILA.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.09
Q2 2024
EPS Surprise History
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 30, 2024 | — | $-0.09 | — | — |
Q2 2024 | May 29, 2024 | — | $-0.09 | — | — |
Q1 2024 | Feb 28, 2024 | — | $-0.06 | — | — |
Q4 2023 | Oct 25, 2023 | — | $-0.08 | — | — |
Q3 2023 | Aug 23, 2023 | — | $-0.17 | — | — |
Q2 2023 | Apr 26, 2023 | — | $-1.62 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.34 | — | — |
Q4 2022 | Oct 26, 2022 | — | $0.04 | — | — |
Q3 2022 | Aug 26, 2022 | — | $-0.65 | — | — |
Q2 2022 | Apr 27, 2022 | — | $-1.11 | — | — |
Q1 2022 | Feb 18, 2022 | — | $-0.33 | — | — |
Q4 2021 | Oct 26, 2021 | — | $-0.34 | — | — |
Q3 2021 | Jul 15, 2021 | — | $-0.15 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.30 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.33 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PILA.ST
What is PILA.ST's current stock price?
Pila Pharma AB (publ) (PILA.ST) is currently trading at $2.20 per share. The stock has moved +2.80% today.
What is the analyst price target for PILA.ST?
No analyst price targets are currently available for this stock.
What sector is Pila Pharma AB (publ) in?
Pila Pharma AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is PILA.ST's market cap?
Pila Pharma AB (publ) has a market capitalization of $0.09 billion, making it a small-cap company.
Does PILA.ST pay dividends?
No, Pila Pharma AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACTI.ST
Active Biotech AB (publ)
$0.04
Mkt Cap: $0.1B
ATORX.ST
Alligator Bioscience AB (publ)
$0.34
Mkt Cap: $0.0B
BIOVIC-B.ST
Biovica International AB (publ)
$0.34
Mkt Cap: $0.1B
ICO.ST
Iconovo AB (publ)
$1.14
Mkt Cap: $0.1B
LXB.ST
Luxbright AB (publ)
$0.45
Mkt Cap: $0.1B
NICA.ST
Nanologica AB (publ)
$0.71
Mkt Cap: $0.1B
NXTCL.ST
NextCell Pharma AB
$0.70
Mkt Cap: $0.1B
ONCOZ.ST
OncoZenge AB (publ)
$6.55
Mkt Cap: $0.1B
SPAGO.ST
Spago Nanomedical AB (publ)
$0.10
Mkt Cap: $0.0B
SPRINT.ST
Sprint Bioscience AB (publ)
$1.45
Mkt Cap: $0.2B
Explore stocks similar to PILA.ST for comparison